Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Merck Sharp & Dohme LLC | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This survey aims to analyze how adherence to treatment, using Ask-20 questionnaire and prescription count, influences level of asthma control in a sample of patients with severe and moderate-mild asthma.
Duration of illness, poor adherence to treatment, gender, smoking habit, obesity, concomitant diseases (rhinitis, sinusitis or gastroesophageal reflux) and concomitant psychiatric disorders may be responsible for an increase and perpetuation of the inflammatory response as well as a decreased response to treatment and may be easily identified clinically.
PRIMARY OBJECTIVES: a) analyze how adherence to treatment, using ASK-20 questionnaire and prescription count, influences level of asthma control in a sample of patients with severe and moderate-mild asthma.
SECONDARY OBJECTIVES: a) analyze the relation between the level of asthma control according to the Asthma Control Test (ACT) score and the fraction exhaled of nitric oxide (FeNO); b) analyze the relation between the level of asthma control according to the ACT score and the gender. c) analyze the relation between the level of asthma control according to the ACT score and smoking habit. d) analyze the correlation between the level of asthma control according to the ACT score and obesity. e) analyze the relation between the level of asthma control according to the ACT score and concomitant diseases (rhinitis, sinusitis or gastroesophageal reflux). f) analyze the relation between the level of asthma control according to the ACT score and concomitant psychiatric disorders. g) analyze the relation between the level of asthma control according to the ACT score and disease severity under the terms proposed by Global Initiative for Asthma (GINA).
METHOD: This is a observational cross-sectional study that includes a sample made up of 50 patients with good asthma control and 50 patients with poor asthma control according to the Asthma Control Test(ACT).
DEVELOPMENT OF THE STUDY After signing the informed consent, data will be collected including gender, smoking habit, alcohol consumption, environmental and employment factors, weight, height, body mass index (BMI), history of atopy, disease severity, rhinosinusitis, gastroesophageal reflux and concomitant psychiatric disorders and a standard physical examination. Measurement of asthma control with Asthma Control Test (ACT)will be performed. Then fraction exhaled of nitric oxide (FeNO)measurement and pulmonary function testing (forced spirometry and bronchodilator test) will be performed .
DEVICES AND MEASUREMENTS: Clinical variables will be collected in a case report form (CRF) specially developed for the study. Functional study: The spirometry will be performed according to the recommendations of European Respiratory Society using the Jaeger Master Lab system.
Bronchodilator test will be performed with albuterol and ipratropium bromide inhalation solution. FeNO levels will be measured of using the Filt's Vario analyzer which allows for bronchial or nasal tests, with a flow and volume meter Lilly-type pneumotachograph . Adherence to treatment will be assessed with the ASK-20 questionnaire and reviewing the number of prescriptions for asthma during the last 6 months.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Analyze How Adherence to Treatment Using ASK-20 Questionnaire Influences Level of Asthma Control. | The ASK-20 (Adherence Starts with Knowledge)is a brief, self-reported instrument developed to identify patient-specific barriers to medication adherence and to improve provider/patient communication about adherence. Programs incorporating a clinical assessment tool such as the ASK-20 for identifying a broad range of risk factors for nonadherence and for developing patient-specific intervention may reduce adherence barriers and improve disease control and ability to perform daily activities in patients with asthma. To gauge the overall risk of nonadherence, the total ASK-20 score was calculated,as the sum of the individual item score, ranging from 1 to 5 and therefore total ranges score from 20 (less barriers to adherence) to 100 (more barriers). | 4 weeks |
| Analyze How Adherence to Treatment Using Prescription Account Influences Level of Asthma Control. | Analyze how adherence to treatment using prescription count influences level of asthma control in a sample of patients with severe and moderate-mild asthma. The second primary endpoint analyzes how adherence, using prescription counts, influences the level of asthma control. Good adherence to treatment was defined as a count of prescriptions issued by their family physician greater than 80% of the required treatment during the last 6 months. Asthma control was measured by Asthma Control Test (ACT). Bad control if ACT score < or = 19 . Good control if ACT score > 19. | 4 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Fraction Exhaled of Nitric Oxide (FeNO) According to Level of Asthma Control. | Analyze the relation between the level of asthma control according to the Asthma Control Test (ACT) scores and the fraction exhaled of nitric oxide (FeNO). Units FENO: ppb (parts per billion). Asthma control was measured by Asthma Control Test(ACT). Bad control if ACT score < or = 19 . Good control if ACT score > 19. |
Not provided
Inclusion Criteria:
Patients with a diagnosis of asthma according to the Global Initiative for Asthma (GINA)guideline criteria .
Exclusion Criteria:
Not provided
Not provided
Patients with ASTHMA will be categorized into two subgroups: a) 50 patients with good asthma control according to the Asthma Control Test (ACT) score; b) 50 patients with bad control asthma according to the ACT score.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Carlos Almonacid Sanchez, Phd, MD | Sociedad Española de Neumología y Cirugía Torácica | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Universitario de Guadalajara | Guadalajara | Castille-La Mancha | 19002 | Spain |
Not provided
Dates of recruitment: Jan 2011 to Jan 2012. Location: medical clinic. Sampling method: Non-Probability Sample. Ages Eligible for Study: 16 yars to 80 years. Genders Eligible for Study: both.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Bad Control | Patient group with bad control defined as participants with an Asthma Control Test (ACT) = or < 19 points. |
| FG001 | Good Control | Patient group with good control defined as participants with an Asthma Control Test (ACT)> 19 points. |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Asthmatic Patients | Patient group with bad control defined as participants with an Asthma Control Test (ACT) score = or < 19. Patient group with good control defined as participants with an Asthma Control Test (ACT)score > 19. In both groups there were patients with mild, moderate and severe asthma according the Global Initiative for Asthma (GINA). |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Analyze How Adherence to Treatment Using ASK-20 Questionnaire Influences Level of Asthma Control. | The ASK-20 (Adherence Starts with Knowledge)is a brief, self-reported instrument developed to identify patient-specific barriers to medication adherence and to improve provider/patient communication about adherence. Programs incorporating a clinical assessment tool such as the ASK-20 for identifying a broad range of risk factors for nonadherence and for developing patient-specific intervention may reduce adherence barriers and improve disease control and ability to perform daily activities in patients with asthma. To gauge the overall risk of nonadherence, the total ASK-20 score was calculated,as the sum of the individual item score, ranging from 1 to 5 and therefore total ranges score from 20 (less barriers to adherence) to 100 (more barriers). | Posted | Median | Inter-Quartile Range | units on a scale | 4 weeks |
|
This is a cross-sectional study in which all data are collected in a single visit. There is no treatment previously modified or new drugs were tested. No intervention was performed so it can not be collected any adverse effects.
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Bad Control Asthmatic Patients | Patients with asthma and bad control evaluated by Asthma Control Test. Good control less than 20 score. |
Not provided
Not provided
This is an observational (cross-sectional )study, with the limitations and biases associated. Patients have not been randomized.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr. Carlos Almonacid | SESCAM - HOSPITAL UNIVERSITARIO DE GUADALAJARA | +34 655 53 44 75 | caralmsan@gmail.com |
Not provided
| ID | Term |
|---|---|
| D001249 | Asthma |
| ID | Term |
|---|---|
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 4 weeks |
| Gender According to Level of Asthma Control. | Analyze the relation between the level of asthma control according to the Asthma Control Test (ACT) scores and the gender. Asthma control was measured by Asthma Control Test(ACT). Good control if ACT score > 19. Bad control if ACT score < or = 19. | 4 weeks |
| Smoking Habit According to Level of Asthma Control. | Analyze the relation between the level of asthma control according to the Asthma Control Test (ACT) score and smoking habit. Good control if ACT score > 19. Bad control if ACT score < or = 19. Patients were divided into three types: active smokers, former smokers and people who had never smoked. | 4 weeks |
| Obesity According to Level of Asthma Control. | Analyze the correlation between the level of asthma control according to the Asthma Control Test (ACT) score and obesity, measured by body mass index(BMI). If BMI (18-25) = normal. If BMI (25 - 29) = overweight. If BMI > 30 obesity. Asthma control was measured by Asthma Control test (ACT). Good control if ACT score > 19. Bad control if ACT score < or = 19 . | 4 weeks |
| Rhinitis According to Level of Asthma Control. | Analyze the relation between the level of asthma control according to the Asthma Control Test (ACT) score and rhinitis. Asthma control was measured by Asthma Control Test (ACT). Good control if ACT score > 19. Bad control if ACT score < or = 19. Rhinitis was diagnosed by symptoms, according to Allergic Rhinitis and its Impact on Asthma(ARIA)guideline. | 4 weeks |
| Sinusitis According to Level of Asthma Control. | Analyze the relation between the level of asthma control according to the Asthma Control Test (ACT) Score and Sinusitis. Asthma control was measured by Asthma Control Test (ACT). Bad control if ACT score < or = 19. Good control if ACT score > 19. Diagnosis of sinusitis was established according to The European Position Paper on Rhinosinusitis and Nasal Polyps (EP3OS) group. | 4 weeks |
| Gastroesophageal Reflux According to Level of Asthma Control. | Analyze the relation Between the Level of Asthma Control According to the ACT Score and gastroesophageal reflux. Gastroesophageal reflux was diagnosed by symptoms or previous diagnosis in their medical records with or without treatment for reflux. Asthma control was measured by Asthma Control Test (ACT). Bad control if ACT score < or = 19. Good control if ACT score > 19. | 4 weeks |
| Concomitant Psychiatric Disorders According to Level of Asthma Control. | Analyze the relation between the level of asthma control according to the Asthma Control Test (ACT) score and concomitant psychiatric disorders. Depression and anxiety were the concomitant psychiatric disorders. Asthma control was measured by Asthma Control Test (ACT). Bad control if ACT score < or = 19. Good control if ACT score > 19. | 4 weeks |
| Pulmonary Function Test (Spirometry) According to Level of Asthma Control. | Analyze the relation between the level of asthma control according to the ACT scores and pulmonary function test (spirometry). Functional study. The Master Lab system (Jaeger, Wurzburg, Germany) was used to obtain spirometry parameters Respiratory function tests were performed according to the recommendations of the European Respiratory Society. The predicted values used for pulmonary function variables were obtained from the European Community for Coal and Steel. This will be performed according to the recommendations of European Respiratory Society using the Jaeger Master Lab system. Asthma control was measured by Asthma Control Test (ACT). Bad control if ACT score < or = 19. Good control if ACT score > 19. | 4 months |
| Asthma Severity According to Level of Asthma Control. | Analyze the relation Between the Level of Asthma Control According to the Asthma Control Test (ACT) Score and asthma severity according the Global Initiative for Asthma (GINA). Asthma control was measured by Asthma Control Test (ACT). Bad control if ACT score < or = 19. Good control if ACT score > 19. | 4 months |
| Participants |
|
| Age Continuous | Mean | Standard Deviation | years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
Patients with asthma and bad control evaluated by Asthma Control Test. Bad control if ACT score < or = 19 .
| OG001 | Good Control | Patients with asthma and good control evaluated by Asthma Control Test (ACT). Good control if ACT score > 19. |
|
|
|
| Secondary | Fraction Exhaled of Nitric Oxide (FeNO) According to Level of Asthma Control. | Analyze the relation between the level of asthma control according to the Asthma Control Test (ACT) scores and the fraction exhaled of nitric oxide (FeNO). Units FENO: ppb (parts per billion). Asthma control was measured by Asthma Control Test(ACT). Bad control if ACT score < or = 19 . Good control if ACT score > 19. | The same as primary outcome. | Posted | Median | Inter-Quartile Range | units on a scale (parts per billion) | 4 weeks |
|
|
|
|
| Secondary | Gender According to Level of Asthma Control. | Analyze the relation between the level of asthma control according to the Asthma Control Test (ACT) scores and the gender. Asthma control was measured by Asthma Control Test(ACT). Good control if ACT score > 19. Bad control if ACT score < or = 19. | Posted | Number | participants | 4 weeks |
|
|
|
|
| Secondary | Smoking Habit According to Level of Asthma Control. | Analyze the relation between the level of asthma control according to the Asthma Control Test (ACT) score and smoking habit. Good control if ACT score > 19. Bad control if ACT score < or = 19. Patients were divided into three types: active smokers, former smokers and people who had never smoked. | Posted | Number | participants | 4 weeks |
|
|
|
|
| Secondary | Obesity According to Level of Asthma Control. | Analyze the correlation between the level of asthma control according to the Asthma Control Test (ACT) score and obesity, measured by body mass index(BMI). If BMI (18-25) = normal. If BMI (25 - 29) = overweight. If BMI > 30 obesity. Asthma control was measured by Asthma Control test (ACT). Good control if ACT score > 19. Bad control if ACT score < or = 19 . | Posted | Number | participants | 4 weeks |
|
|
|
|
| Secondary | Rhinitis According to Level of Asthma Control. | Analyze the relation between the level of asthma control according to the Asthma Control Test (ACT) score and rhinitis. Asthma control was measured by Asthma Control Test (ACT). Good control if ACT score > 19. Bad control if ACT score < or = 19. Rhinitis was diagnosed by symptoms, according to Allergic Rhinitis and its Impact on Asthma(ARIA)guideline. | Posted | Number | participants | 4 weeks |
|
|
|
|
| Secondary | Sinusitis According to Level of Asthma Control. | Analyze the relation between the level of asthma control according to the Asthma Control Test (ACT) Score and Sinusitis. Asthma control was measured by Asthma Control Test (ACT). Bad control if ACT score < or = 19. Good control if ACT score > 19. Diagnosis of sinusitis was established according to The European Position Paper on Rhinosinusitis and Nasal Polyps (EP3OS) group. | Posted | Number | participants | 4 weeks |
|
|
|
|
| Secondary | Gastroesophageal Reflux According to Level of Asthma Control. | Analyze the relation Between the Level of Asthma Control According to the ACT Score and gastroesophageal reflux. Gastroesophageal reflux was diagnosed by symptoms or previous diagnosis in their medical records with or without treatment for reflux. Asthma control was measured by Asthma Control Test (ACT). Bad control if ACT score < or = 19. Good control if ACT score > 19. | Posted | Number | participants | 4 weeks |
|
|
|
|
| Secondary | Concomitant Psychiatric Disorders According to Level of Asthma Control. | Analyze the relation between the level of asthma control according to the Asthma Control Test (ACT) score and concomitant psychiatric disorders. Depression and anxiety were the concomitant psychiatric disorders. Asthma control was measured by Asthma Control Test (ACT). Bad control if ACT score < or = 19. Good control if ACT score > 19. | Posted | Number | participants | 4 weeks |
|
|
|
|
| Primary | Analyze How Adherence to Treatment Using Prescription Account Influences Level of Asthma Control. | Analyze how adherence to treatment using prescription count influences level of asthma control in a sample of patients with severe and moderate-mild asthma. The second primary endpoint analyzes how adherence, using prescription counts, influences the level of asthma control. Good adherence to treatment was defined as a count of prescriptions issued by their family physician greater than 80% of the required treatment during the last 6 months. Asthma control was measured by Asthma Control Test (ACT). Bad control if ACT score < or = 19 . Good control if ACT score > 19. | Posted | Number | participants | 4 weeks |
|
|
|
|
| Secondary | Pulmonary Function Test (Spirometry) According to Level of Asthma Control. | Analyze the relation between the level of asthma control according to the ACT scores and pulmonary function test (spirometry). Functional study. The Master Lab system (Jaeger, Wurzburg, Germany) was used to obtain spirometry parameters Respiratory function tests were performed according to the recommendations of the European Respiratory Society. The predicted values used for pulmonary function variables were obtained from the European Community for Coal and Steel. This will be performed according to the recommendations of European Respiratory Society using the Jaeger Master Lab system. Asthma control was measured by Asthma Control Test (ACT). Bad control if ACT score < or = 19. Good control if ACT score > 19. | Posted | Mean | Standard Deviation | percentage of the theoretical | 4 months |
|
|
|
|
| Secondary | Asthma Severity According to Level of Asthma Control. | Analyze the relation Between the Level of Asthma Control According to the Asthma Control Test (ACT) Score and asthma severity according the Global Initiative for Asthma (GINA). Asthma control was measured by Asthma Control Test (ACT). Bad control if ACT score < or = 19. Good control if ACT score > 19. | Posted | Number | participants | 4 months |
|
|
|
|
| 0 |
| 0 |
| 0 |
| 0 |
| EG001 | Good Control | Patients with asthma and good control evaluated by Asthma Control Test. Good control more than 19 score. | 0 | 0 | 0 | 0 |
Not provided
Not provided
Not provided
| D012130 |
| Respiratory Hypersensitivity |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |
| former smoker |
|
| Odds Ratio (OR) |
| 1.038 |
| 2-Sided |
| 95 |
| 1.012 |
| 1.065 |
| No |
| Superiority or Other |